Cargando…

USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY

INTRODUCTION: COVID-19 vaccine hesitancy among healthcare workers (HCW) remains due to misconceptions. Our study attempts to improve vaccination rates among vaccine-hesitant healthcare workers as part of COVID-19 Vaccine Allergy Program. METHODS: We enrolled 38 vaccine-hesitant HCWs in the COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, S., Kaunang, J., Zeana, C., Grodman, H., Purswani, M., Persaud, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646416/
http://dx.doi.org/10.1016/j.anai.2022.08.545
_version_ 1784827161571491840
author Mohammed, S.
Kaunang, J.
Zeana, C.
Grodman, H.
Purswani, M.
Persaud, Y.
author_facet Mohammed, S.
Kaunang, J.
Zeana, C.
Grodman, H.
Purswani, M.
Persaud, Y.
author_sort Mohammed, S.
collection PubMed
description INTRODUCTION: COVID-19 vaccine hesitancy among healthcare workers (HCW) remains due to misconceptions. Our study attempts to improve vaccination rates among vaccine-hesitant healthcare workers as part of COVID-19 Vaccine Allergy Program. METHODS: We enrolled 38 vaccine-hesitant HCWs in the COVID-19 Vaccine Allergy program. A questionnaire assessed their risk and concerns. They were then offered COVID-19 vaccine evaluation and skin prick testing(SPT). RESULTS: Among 38 participants, reasons for vaccine refusal included: side effects(47%), fear of an allergic reaction(26%), underlying medical conditions(18%), and previous COVID-19 infection(18%). If there were no mandatory orders for COVID-19 vaccination towards HCW, 71% of participants definitely would not get the COVID-19 vaccine, 21% were not likely to get the vaccine, and 8% would likely get the vaccine. 89% of the participant expressed interest in getting the COVID-19 SPT, and 11% showed no interest. Out of 31 participants who had SPT, 97% were negative and 3%(n=1) were positive. Upon follow-up, 71% received COVID-19 vaccine, 23% rejected COVID-19 vaccine, and 6% were lost to follow-up. Regarding those who declined COVID-19 vaccine, 86% refused due to religious exemptions, while 14% had medical exemptions. Of individuals that were either not likely or definitely not likely to receive the COVID-19 vaccine, 69% ultimately received the vaccine. CONCLUSIONS: : Our study showed a preponderance of HCW who were unlikely to get the vaccine, and subsequently agreed to receive it after negative SPT. Thus COVID-19 Vaccine Allergy Program can be used to dispel misinformation and help HCW in the shared decision-making process to improve vaccination rates.
format Online
Article
Text
id pubmed-9646416
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96464162022-11-15 USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY Mohammed, S. Kaunang, J. Zeana, C. Grodman, H. Purswani, M. Persaud, Y. Ann Allergy Asthma Immunol P004 INTRODUCTION: COVID-19 vaccine hesitancy among healthcare workers (HCW) remains due to misconceptions. Our study attempts to improve vaccination rates among vaccine-hesitant healthcare workers as part of COVID-19 Vaccine Allergy Program. METHODS: We enrolled 38 vaccine-hesitant HCWs in the COVID-19 Vaccine Allergy program. A questionnaire assessed their risk and concerns. They were then offered COVID-19 vaccine evaluation and skin prick testing(SPT). RESULTS: Among 38 participants, reasons for vaccine refusal included: side effects(47%), fear of an allergic reaction(26%), underlying medical conditions(18%), and previous COVID-19 infection(18%). If there were no mandatory orders for COVID-19 vaccination towards HCW, 71% of participants definitely would not get the COVID-19 vaccine, 21% were not likely to get the vaccine, and 8% would likely get the vaccine. 89% of the participant expressed interest in getting the COVID-19 SPT, and 11% showed no interest. Out of 31 participants who had SPT, 97% were negative and 3%(n=1) were positive. Upon follow-up, 71% received COVID-19 vaccine, 23% rejected COVID-19 vaccine, and 6% were lost to follow-up. Regarding those who declined COVID-19 vaccine, 86% refused due to religious exemptions, while 14% had medical exemptions. Of individuals that were either not likely or definitely not likely to receive the COVID-19 vaccine, 69% ultimately received the vaccine. CONCLUSIONS: : Our study showed a preponderance of HCW who were unlikely to get the vaccine, and subsequently agreed to receive it after negative SPT. Thus COVID-19 Vaccine Allergy Program can be used to dispel misinformation and help HCW in the shared decision-making process to improve vaccination rates. Published by Elsevier Inc. 2022-11 2022-11-10 /pmc/articles/PMC9646416/ http://dx.doi.org/10.1016/j.anai.2022.08.545 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle P004
Mohammed, S.
Kaunang, J.
Zeana, C.
Grodman, H.
Purswani, M.
Persaud, Y.
USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY
title USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY
title_full USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY
title_fullStr USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY
title_full_unstemmed USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY
title_short USING COVID VACCINE SKIN TESTING IN SHARED DECISION MAKING TO ADDRESS VACCINE HESITANCY
title_sort using covid vaccine skin testing in shared decision making to address vaccine hesitancy
topic P004
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646416/
http://dx.doi.org/10.1016/j.anai.2022.08.545
work_keys_str_mv AT mohammeds usingcovidvaccineskintestinginshareddecisionmakingtoaddressvaccinehesitancy
AT kaunangj usingcovidvaccineskintestinginshareddecisionmakingtoaddressvaccinehesitancy
AT zeanac usingcovidvaccineskintestinginshareddecisionmakingtoaddressvaccinehesitancy
AT grodmanh usingcovidvaccineskintestinginshareddecisionmakingtoaddressvaccinehesitancy
AT purswanim usingcovidvaccineskintestinginshareddecisionmakingtoaddressvaccinehesitancy
AT persaudy usingcovidvaccineskintestinginshareddecisionmakingtoaddressvaccinehesitancy